Rachel C. Harrington

FDA investigator

Appears on 7 documents from 2012 to 2018, most often at sites in Maryland. Most often cites control of microbiological contamination (21 CFR 211.113).

7
Documents on file
8.1
Observations per 483
2012
First seen
2018
Most recent

What they cite most

From 60 observations

Activity by year

2012: 3, 2013: 1, 2014: 1, 2015: 1, 2018: 1

Where

Maryland 2 · Virginia 2 · Nevada 1 · South Korea 1 · West Virginia 1

Is Rachel C. Harrington coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Hanlim Pharm Co., Ltd.Feb 6, 2018 · Yonginsi Ceoin-gu, South Korea
483 Bell-More Laboratories IncMar 13, 2015 · Hampstead, Maryland
483 PharmaLogic CSP, Inc.Dec 12, 2014 · Bridgep ort, West Virginia
483 FVS Holdings, Inc. (dba Green Valley Drugs)Mar 15, 2013 · Henderson, Nevada
483 RxSouth, LLC (dba RX3 Pharmacy)Dec 14, 2012 · Chester, Virginia
483 Rx South, LLC, dba Rx3 PharmacyDec 14, 2012 · Chester, Virginia
483 Bora Pharmaceuticals Injectables Inc.Aug 1, 2012 · Baltimore, Maryland

About this profile

What does Rachel C. Harrington inspect?

Rachel C. Harrington appears on 7 documents on file covering 6 sites, most often in Maryland.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and 21 CFR 211.84.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Rachel C. Harrington is dated Feb 6, 2018.